Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer
Aging · 2023
DOI: 10.18632/aging.204582 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging, 2023. Verfasst von Yu Zeng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Lab…. Hauptthemen laut MEDLINE: Thyroid Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Papillary thyroid cancer (PTC) is one of the most common malignant tumors in female, and estrogen can affect its progression. However, the targets and mechanisms of estrogen action in PTC remain unclear. Therefore, this study focuses on the relationship between estrogen-related genes (ERGs) expression and prognosis in PTC, particularly neuropeptide U (NMU), and its important role in tumor progression. Based on The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases, differentially expressed genes (DEGs) predominantly enriched in ERGs were identified between PTC and normal tissue. Then, we identified ERGs that contributed most to PTC prognosis, including Transducer of ERBB2 1 (TOB1), trefoil factor 1 (TFF1), phospholipase A and acyltransferase 3 (PLAAT3), NMU, kinesin family member 20A (KIF20A), DNA topoisomerase II alpha (TOP2A), tetraspanin 13 (TSPAN13), and carboxypeptidase E (CPE). In addition, we confirmed that NMU was highly expressed in PTC and explored the effect of NMU on PTC cells proliferation in vitro and in vivo. The results showed that the proliferative capacity of PTC cells was significantly reduced with NMU knockdown. Moreover, the phosphorylation levels of the Kirsten rat sarcoma virus (KRAS) signaling pathway were significantly lower with NMU knockdown. These results suggest that ERGs, especially NMU, may be novel prognostic indicators in PTC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thyroid and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research…
- Department of Cancer Prevention Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Researc…
- The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan 511500, China.
- Department of Thyroid and Breast Surgery, Tianjin Union Medical Center, Tianjin 300121, China.
- School of Medicine, Nankai University, Tianjin 300071, China.
- Tianjin Key Laboratory of General Surgery in Construction, Tianjin Union Medical Center, Tianjin 300121, China.
Zitieren
APA
Zeng, Y., Ma, W., Li, L., Zhuang, G., Luo, G., Zhou, H., Hao, W., Liu, Y., Guo, F., Tian, M., Ruan, X., Gao, M., & Zheng, X. (2023). Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer. Aging. https://doi.org/10.18632/aging.204582
Vancouver
Zeng Y, Ma W, Li L, Zhuang G, Luo G, Zhou H, et al. Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer. Aging. 2023. doi:10.18632/aging.204582
BibTeX
@article{Zeng2023,
author = {Zeng, Yu and Ma, Weike and Li, Lijuan and Zhuang, Gaojian and Luo, Guoqing and Zhou, Hong and Hao, Weijing and Liu, Yu and Guo, Fengli and Tian, Mengran and Ruan, Xianhui and Gao, Ming and Zheng, Xiangqian},
title = {Identification and validation of eight estrogen-related genes for predicting prognosis of papillary thyroid cancer},
journal = {Aging},
year = {2023},
doi = {10.18632/aging.204582}
}
EUVIMED